{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/668f6b0123d7b7c419cf4794/69e0b27a907e5a7cc25a5916?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"\"Off the Scales - The Inside Story of Ozempic\" ...with Reuters Journalist Aimee Donnellan","description":"<p>Professor Collins talks with Reuters journalist Aimee Donnellan about her book \"Off the Scales\" which details the story of intrigue and perseverance behind the discovery and development of Ozempic, a GLP-1 Receptor Agonist (RA) drug. Their conversation covers the pivotal scientific developments over the long journey of bringing this medication to market and the important stories of the overlooked women scientists who made key contributions to this research. They discuss some broad societal impact of medications like Ozempic, and Aimee shares insights from some of the people she interviewed for her book  about how Ozempic affected their life and health. Given medications for obesity treatment are here to stay, this episode raises awareness about the science, ethics, medication usage and the future of management approaches to optimise weight related health and wellbeing.</p><p><br></p><p><strong>Key&nbsp;topics</strong></p><ol><li>The science and development of Ozempic and GLP-1 RA medications</li><li>The societal and health impact of diabetes and obesity management drugs</li><li>The history of research o develop Ozempic and recognition of obesity as a disease</li></ol><p><br></p><p><strong>Resources</strong></p><p>\"Off the Scales - The Inside Story of Ozempic and the Race to Cure Obesity\" by Amy Donnellan <a href=\"https://www.qbd.com.au/off-the-scales-the-inside-story-of-ozempic-and-the-race-to-cure-obesity/aimee-donnellan/9780008719098/\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.qbd.com.au/off-the-scales-the-inside-story-of-ozempic-and-the-race-to-cure-obesity/aimee-donnellan/9780008719098/</a></p><p>World Health Organization Guideline on GLP-1 RAs <a href=\"https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity</a></p><p><br></p><p><strong>To access the Healthy Eating Quiz: </strong>Click on the top right hand 'green button' called 'How healthy is my diet' <strong> </strong><a href=\"https://nomoneynotime.com.au/\" rel=\"noopener noreferrer\" target=\"_blank\">https://nomoneynotime.com.au/</a></p><p><strong>Want a more Personalised Food, Nutrient Assessment Report? Use our Australian Eating Survey -</strong> For a 50% discount enter the '<strong>DietCheck' code </strong>at the checkout! <strong>Purchase here </strong><a href=\"https://australianeatingsurvey.com.au/\" rel=\"noopener noreferrer\" target=\"_blank\">https://australianeatingsurvey.com.au/</a></p><p><br></p><p>Here's the link to the <strong>No Money No Time closed Facebook group</strong> (be sure to take the Healthy Eating Quiz first) <a href=\"https://www.facebook.com/groups/386824626838448\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.facebook.com/groups/386824626838448</a></p><p><strong>Our No Money No Time </strong>email: nmnt@newcastle.edu.au and our Nutrition Science Bites email: nutritionsciencebites@newcastle.edu.au&nbsp;</p><p><br></p><p><strong>Keywords: </strong>#Ozempic, #GLP1, #obesity, #weightmanagement, #AimeeDonnellan, #pharmaceuticalindustry, #health, #stigma, #sciencehistory, #drugdevelopment, #publichealth, #type2diabetes, #semaglutide</p><p> #NutritionScienceBites</p>","author_name":"Clare Collins"}